BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 29355135)

  • 1. Shorter & cheaper regimen to treat multidrug-resistant tuberculosis: A new hope.
    Prasad R; Gupta N; Banka A
    Indian J Med Res; 2017 Sep; 146(3):301-303. PubMed ID: 29355135
    [No Abstract]   [Full Text] [Related]  

  • 2. BPaL approved for multidrug-resistant tuberculosis.
    Burki T
    Lancet Infect Dis; 2019 Oct; 19(10):1063-1064. PubMed ID: 31559963
    [No Abstract]   [Full Text] [Related]  

  • 3. Bedaquiline.
    Goulooze SC; Cohen AF; Rissmann R
    Br J Clin Pharmacol; 2015 Aug; 80(2):182-4. PubMed ID: 25702772
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid emergence of
    Veziris N; Bernard C; Guglielmetti L; Le Du D; Marigot-Outtandy D; Jaspard M; Caumes E; Lerat I; Rioux C; Yazdanpanah Y; Tiotiu A; Lemaitre N; Brossier F; Jarlier V; Robert J; Sougakoff W; Aubry A; ;
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28182568
    [No Abstract]   [Full Text] [Related]  

  • 5. Current issues with the use of bedaquiline.
    Kakkar AK; Dahiya N
    Ann Pharmacother; 2014 May; 48(5):666. PubMed ID: 24519480
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to comments by Kakkar and Dahiya.
    Chahine EB; Karaoui L; Mansour H
    Ann Pharmacother; 2014 May; 48(5):667. PubMed ID: 24733170
    [No Abstract]   [Full Text] [Related]  

  • 7. Bedaquiline and delamanid in combination for treatment of drug-resistant tuberculosis.
    Mohr E; Ferlazzo G; Hewison C; De Azevedo V; Isaakidis P
    Lancet Infect Dis; 2019 May; 19(5):470. PubMed ID: 31034392
    [No Abstract]   [Full Text] [Related]  

  • 8. Combating drug-resistant tuberculosis: the unexpected benefits of bedaquiline.
    Furin J; Diacon AH; Andries K
    Int J Tuberc Lung Dis; 2017 Jan; 21(1):4-5. PubMed ID: 28157457
    [No Abstract]   [Full Text] [Related]  

  • 9. Bedaquiline or delamanid for rifampin-resistant tuberculosis?
    Lessem E; Cox V; Furin J
    Lancet Respir Med; 2017 Oct; 5(10):772-774. PubMed ID: 28887015
    [No Abstract]   [Full Text] [Related]  

  • 10. Multidrug-resistant tuberculosis and bedaquiline.
    Salfinger M; Somoskövi A
    N Engl J Med; 2014 Dec; 371(25):2435-6. PubMed ID: 25517715
    [No Abstract]   [Full Text] [Related]  

  • 11. Multidrug-resistant tuberculosis and bedaquiline.
    Diacon AH; Lounis N; Dannemann B
    N Engl J Med; 2014 Dec; 371(25):2436. PubMed ID: 25517714
    [No Abstract]   [Full Text] [Related]  

  • 12. Belarus and drug-resistant tuberculosis.
    Bull World Health Organ; 2019 Dec; 97(12):795-796. PubMed ID: 31819286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial experience of bedaquiline use in a series of drug-resistant tuberculosis patients from India.
    Udwadia ZF; Amale RA; Mullerpattan JB
    Int J Tuberc Lung Dis; 2014 Nov; 18(11):1315-8. PubMed ID: 25299863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bedaquiline (Sirturo) for multidrug-resistant tuberculosis.
    Med Lett Drugs Ther; 2013 Aug; 55(1423):66-8. PubMed ID: 23959388
    [No Abstract]   [Full Text] [Related]  

  • 15. Bedaquiline: a new hope to treat multi-drug resistant tuberculosis.
    Patel RV; Riyaz SD; Park SW
    Curr Top Med Chem; 2014; 14(16):1866-74. PubMed ID: 25262806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA approval of bedaquiline--the benefit-risk balance for drug-resistant tuberculosis.
    Cox E; Laessig K
    N Engl J Med; 2014 Aug; 371(8):689-91. PubMed ID: 25140952
    [No Abstract]   [Full Text] [Related]  

  • 17. Switching to bedaquiline for treatment of rifampicin-resistant tuberculosis in South Africa: A retrospective cohort analysis.
    Bouton TC; de Vos M; Ragan EJ; White LF; Van Zyl L; Theron D; Horsburgh CR; Warren RM; Jacobson KR
    PLoS One; 2019; 14(10):e0223308. PubMed ID: 31622366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bedaquiline Microheteroresistance after Cessation of Tuberculosis Treatment.
    de Vos M; Ley SD; Wiggins KB; Derendinger B; Dippenaar A; Grobbelaar M; Reuter A; Dolby T; Burns S; Schito M; Engelthaler DM; Metcalfe J; Theron G; van Rie A; Posey J; Warren R; Cox H
    N Engl J Med; 2019 May; 380(22):2178-2180. PubMed ID: 31141643
    [No Abstract]   [Full Text] [Related]  

  • 19. Multidrug-resistant tuberculosis and culture conversion with bedaquiline.
    Diacon AH; Pym A; Grobusch MP; de los Rios JM; Gotuzzo E; Vasilyeva I; Leimane V; Andries K; Bakare N; De Marez T; Haxaire-Theeuwes M; Lounis N; Meyvisch P; De Paepe E; van Heeswijk RP; Dannemann B;
    N Engl J Med; 2014 Aug; 371(8):723-32. PubMed ID: 25140958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bedaquiline-Resistant Tuberculosis: Dark Clouds on the Horizon.
    Andres S; Merker M; Heyckendorf J; Kalsdorf B; Rumetshofer R; Indra A; Hofmann-Thiel S; Hoffmann H; Lange C; Niemann S; Maurer FP
    Am J Respir Crit Care Med; 2020 Jun; 201(12):1564-1568. PubMed ID: 32053752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.